S100B promotes the proliferation, migration and invasion of specific brain metastatic lung adenocarcinoma cell line

Cell Biochemistry and Function

Volumn 29, Issue 7, 2011, Pages 582-588

  Jiang, Weifeng ^a   Jia, Qianxin ^b   Liu, Lili ^a   Zhao, Xinwen ^a   Tan, Aixing ^a   Ma, Ningqiang ^a   Zhang, Helong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 73131 People's Liberation Army Hospital   (China)

Author keywords

Brain metastasis; Invasion; Migration; Non small cell lung cancer; Proliferation; RNAi; S100B

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN S100B; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BRAIN METASTASIS; CARCINOMA CELL; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION;

ADENOCARCINOMA; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; BRAIN NEOPLASMS; BROMODEOXYURIDINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; RNA, SMALL INTERFERING; S100 PROTEINS; TRANSFECTION;

EID: 84860392771     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1791     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA: a Cancer Journal for Clinicians 2008; 58: 71-96.
2. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. Journal of Neuro-Oncology 2005; 75: 5-14.
3. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94: 2698-2705.
4. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. Journal of Clinical Oncology 2004; 22: 1589-1597.
5. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Reviews 1989; 8: 98-101.
6. Simpson JE, Ince PG, Lace G, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiology of Aging 2010; 31: 578-590.
7. Nylen K, Ost M, Csajbok LZ, et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochirurgica (Wien) 2008; 150: 221-227.
8. Bellander BM, Olafsson IH, Ghatan PH, et al. Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B. Acta Neurochirurgica (Wien) 2010; 153: 90-100.
9. Vogelbaum MA, Masaryk T, Mazzone P, et al. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. Cancer 2005; 104: 817-824.
10. Marchi N, Mazzone P, Fazio V, Mekhail T, Masaryk T, Janigro D. ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients. Cancer 2008; 112: 1313-1324.
11. Zhang JQ, Zhang HL, Feng YM, Ma L. Establishment of highly brain metastatic lung cancer cell sub-clone and brain metastatic animal model. J Mod Oncol 2007; 15: 494-496.
12. Hu L, Zhang JQ, Zhu H, Min J, Feng YM, Zhang HL. Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma. Medical Oncology 2010; 27: 708-714.
13. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and -independent interactions of the S100 protein family. Biochemical Journal 2006; 396: 201-214.
14. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The International Journal of Biochemistry & Cell Biology 2001; 33: 637-668.
15. Sedaghat F, Notopoulos A. S100 protein family and its application in clinical practice. Hippokratia 2008; 12: 198-204.
16. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Research Bulletin 1995; 37: 417-429.
17. Park HR, Min SK. Expression of S100A2 and S100B proteins in epithelial tumors of the skin. Journal of Cutaneous Pathology 2003; 30: 373-378.
18. Ji JF, Zhao LQ, Wang XQ, et al. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 2004; 130: 480-486.
19. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Frontiers in Bioscience 2002; 7: 1356-1368.
20. Ikonomidou C, Bittigau P, Ishimaru MJ, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287: 1056-1060.
21. Yang J, Wang JH, Zhu SS, et al. C-reactive protein augments hypoxia-induced apoptosis through mitochondrion-dependent pathway in cardiac myocytes. Molecular and Cellular Biochemistry 2008; 310: 215-226.
22. Druse MJ, Gillespie RA, Tajuddin NF, Rich M. S100B-mediated protection against the pro-apoptotic effects of ethanol on fetal rhombencephalic neurons. Brain Research 2007; 1150: 46-54.
23. Zhang XX, Tong NW, Li Y. Concurrently using rosiglitazone prevents glucosamine-induced islet beta-cell apoptosis and dysfunction. Cell Biochemistry and Function 2010; 28: 509-514.
24. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Reviews 1996; 15: 507-525.
25. Link A, Shin SK, Nagasaka T, et al. JC virus mediates invasion and migration in colorectal metastasis. PloS One 2009; 4: e8146.
26. Ning XX, Sun SR, Hong L, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Molecular Cancer Research 2007; 5: 1254-1262.